Tatiana Catanzarite1, Aksharananda Rambachan2, Margaret G Mueller3, Matthew A Pilecki2, John Y S Kim2, Kimberly Kenton3. 1. Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 2. Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abstract
PURPOSE: We identified rates of and risk factors for complications after colpocleisis using the American College of Surgeons NSQIP® database. MATERIALS AND METHODS: Women treated with Le Fort colpocleisis from 2005 to 2011 were identified in the database. Primary outcomes were 30-day complication rates. Secondary outcomes were risk factors for complications and the impact of age and a concomitant sling on morbidity. Clinical and procedural characteristics were compared using the chi-square test and 1-way ANOVA. RESULTS: We identified 283 women, of whom 23 (8.1%) experienced complications. The most common complication was urinary tract infection in 18 women (6.4%). There was 1 death for a 0.4% mortality rate. Increased complications were associated with age less than 75 years (p = 0.03), chronic obstructive pulmonary disease (p = 0.03), hemiplegia (p = 0.03), disseminated cancer (p = 0.03) and open wound infection (p = 0.02). Six patients (2.1%) required return to the operating room within 30 days. Complication rates did not differ based on operative time (p = 0.78), inpatient status (p = 0.24), resident involvement (p = 0.35), concomitant sling placement (p = 0.81) or anesthesia type (p = 0.27). Women undergoing colpocleisis without (191) and with (92) a sling had similar baseline characteristics. Colpocleisis without and with a sling had similar rates of complications (7.9% vs 8.7%, p = 0.81), urinary tract infection (5.8% vs 7.6%, p = 0.55), return to the operating room (2.1% vs 2.2%, p = 0.97) and mortality (0% vs 1.1%, p = 0.15). CONCLUSIONS: Mortality and complication rates after colpocleisis are low with urinary tract infection being the most common postoperative complication. Concomitant sling placement does not increase 30-day complication rates.
PURPOSE: We identified rates of and risk factors for complications after colpocleisis using the American College of Surgeons NSQIP® database. MATERIALS AND METHODS:Women treated with Le Fort colpocleisis from 2005 to 2011 were identified in the database. Primary outcomes were 30-day complication rates. Secondary outcomes were risk factors for complications and the impact of age and a concomitant sling on morbidity. Clinical and procedural characteristics were compared using the chi-square test and 1-way ANOVA. RESULTS: We identified 283 women, of whom 23 (8.1%) experienced complications. The most common complication was urinary tract infection in 18 women (6.4%). There was 1 death for a 0.4% mortality rate. Increased complications were associated with age less than 75 years (p = 0.03), chronic obstructive pulmonary disease (p = 0.03), hemiplegia (p = 0.03), disseminated cancer (p = 0.03) and open wound infection (p = 0.02). Six patients (2.1%) required return to the operating room within 30 days. Complication rates did not differ based on operative time (p = 0.78), inpatient status (p = 0.24), resident involvement (p = 0.35), concomitant sling placement (p = 0.81) or anesthesia type (p = 0.27). Women undergoing colpocleisis without (191) and with (92) a sling had similar baseline characteristics. Colpocleisis without and with a sling had similar rates of complications (7.9% vs 8.7%, p = 0.81), urinary tract infection (5.8% vs 7.6%, p = 0.55), return to the operating room (2.1% vs 2.2%, p = 0.97) and mortality (0% vs 1.1%, p = 0.15). CONCLUSIONS: Mortality and complication rates after colpocleisis are low with urinary tract infection being the most common postoperative complication. Concomitant sling placement does not increase 30-day complication rates.
Authors: Kate V Meriwether; Ethan M Balk; Danielle D Antosh; Cedric K Olivera; Shunaha Kim-Fine; Miles Murphy; Cara L Grimes; Ambereen Sleemi; Ruchira Singh; Alexis A Dieter; Catrina C Crisp; David D Rahn Journal: Int Urogynecol J Date: 2019-02-11 Impact factor: 2.894
Authors: T Clark Powell; Isuzu Meyer; Chee Paul Lin; Kelsey Lipking; Holly E Richter Journal: Female Pelvic Med Reconstr Surg Date: 2021-08-01 Impact factor: 2.091